{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T14:41:23Z","timestamp":1778942483392,"version":"3.51.4"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Analytical Biochemistry"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.ab.2012.10.034","type":"journal-article","created":{"date-parts":[[2012,11,5]],"date-time":"2012-11-05T03:16:18Z","timestamp":1352085378000},"page":"15-25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["A high-throughput screening assay using Krabbe disease patient cells"],"prefix":"10.1016","volume":"434","author":[{"given":"Jameson","family":"Ribbens","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grace","family":"Whiteley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirokazu","family":"Furuya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noel","family":"Southall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Marugan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Ferrer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gustavo H.B.","family":"Maegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ab.2012.10.034_b0005","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/BF02185759","article-title":"Two different mutations are responsible for Krabbe disease in the Druze and Moslem Arab populations in Israel","volume":"97","author":"Rafi","year":"1996","journal-title":"Hum. Genet."},{"key":"10.1016\/j.ab.2012.10.034_b0010","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/(SICI)1098-1004(1997)10:4<268::AID-HUMU2>3.0.CO;2-D","article-title":"Molecular genetics of Krabbe disease (globoid cell leukodystrophy): diagnostic and clinical implications","volume":"10","author":"Wenger","year":"1997","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ab.2012.10.034_b0015","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1007\/s004390050532","article-title":"Adult onset globoid cell leukodystrophy (Krabbe disease): analysis of galactosylceramidase cDNA from four Japanese patients","volume":"100","author":"Furuya","year":"1997","journal-title":"Hum. Genet."},{"key":"10.1016\/j.ab.2012.10.034_b0020","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1399-0004.2010.01572.x","article-title":"Krabbe leukodystrophy in a selected population with high rate of late onset forms: longer survival linked to c.121G>A (p.Gly41Ser) mutation","volume":"80","author":"Fiumara","year":"2011","journal-title":"Clin. Genet."},{"key":"10.1016\/j.ab.2012.10.034_b0025","doi-asserted-by":"crossref","first-page":"15169","DOI":"10.1073\/pnas.1105639108","article-title":"Insights into Krabbe disease from structures of galactocerebrosidase","volume":"108","author":"Deane","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ab.2012.10.034_b0030","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1023\/A:1022436928925","article-title":"Twenty five years of the \u201cpsychosine hypothesis\u201d: a personal perspective of its history and present status","volume":"23","author":"Suzuki","year":"1998","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ab.2012.10.034_b0035","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0022-2275(20)39839-4","article-title":"Krabbe disease: a galactosylsphingosine (psychosine) lipidosis","volume":"21","author":"Svennerholm","year":"1980","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ab.2012.10.034_b0040","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1097\/MOP.0b013e3282f161f2","article-title":"Enzyme reconstitution\/replacement therapy for lysosomal storage diseases","volume":"19","author":"Burrow","year":"2007","journal-title":"Curr. Opin. Pediatr."},{"key":"10.1016\/j.ab.2012.10.034_b0045","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1056\/NEJMoa042604","article-title":"Transplantation of umbilical-cord blood in babies with infantile Krabbe\u2019s disease","volume":"352","author":"Escolar","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ab.2012.10.034_b0050","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/GIM.0b013e3181a16e04","article-title":"The long-term outcomes of presymptomatic infants transplanted for Krabbe disease: report of the workshop held on July 11 and 12, 2008, Holiday Valley, New York","volume":"11","author":"Duffner","year":"2009","journal-title":"Genet. Med."},{"key":"10.1016\/j.ab.2012.10.034_b0055","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000112332","article-title":"Partial enzyme deficiencies: residual activities and the development of neurological disorders","volume":"6","author":"Conzelmann","year":"1983","journal-title":"Dev. Neurosci."},{"key":"10.1016\/j.ab.2012.10.034_b0060","doi-asserted-by":"crossref","first-page":"9150","DOI":"10.1074\/jbc.M609304200","article-title":"Pyrimethamine as a potential pharmacological chaperone for late-onset forms of GM2 gangliosidosis","volume":"282","author":"Maegawa","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ab.2012.10.034_b0065","doi-asserted-by":"crossref","first-page":"23502","DOI":"10.1074\/jbc.M109.012393","article-title":"Identification and characterization of ambroxol as an enzyme enhancement agent for Gaucher disease","volume":"284","author":"Maegawa","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ab.2012.10.034_b0070","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1021\/jm1008902","article-title":"Evaluation of quinazoline analogues as glucocerebrosidase inhibitors with chaperone activity","volume":"54","author":"Marugan","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ab.2012.10.034_b0075","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s00216-011-5496-z","article-title":"A high throughput glucocerebrosidase assay using the natural substrate glucosylceramide","volume":"402","author":"Motabar","year":"2012","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.ab.2012.10.034_b0080","doi-asserted-by":"crossref","first-page":"13192","DOI":"10.1073\/pnas.0705637104","article-title":"Three classes of glucocerebrosidase inhibitors identified by quantitative high-throughput screening are chaperone leads for Gaucher disease","volume":"104","author":"Zheng","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ab.2012.10.034_b0085","doi-asserted-by":"crossref","first-page":"e29504","DOI":"10.1371\/journal.pone.0029504","article-title":"Novel patient cell-based HTS assay for identification of small molecules for a lysosomal storage disease","volume":"6","author":"Geng","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ab.2012.10.034_b0090","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0009-8981(05)80003-8","article-title":"Characterization of 6-hexadecanoylamino-4-methylumbelliferyl-\u03b2-d-galactopyranoside as fluorogenic substrate of galactocerebrosidase for the diagnosis of Krabbe disease","volume":"205","author":"Wiederschain","year":"1992","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ab.2012.10.034_b0095","doi-asserted-by":"crossref","first-page":"5489","DOI":"10.1523\/JNEUROSCI.6383-09.2010","article-title":"Molecular characterization of mutations that cause globoid cell leukodystrophy and pharmacological rescue using small molecule chemical chaperones","volume":"30","author":"Lee","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ab.2012.10.034_b0100","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein\u2013dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ab.2012.10.034_b0105","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0009-8981(97)06527-3","article-title":"Model SV40-transformed fibroblast lines for metabolic studies of human prosaposin and acid ceramidase deficiencies","volume":"262","author":"Chatelut","year":"1997","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ab.2012.10.034_b0110","doi-asserted-by":"crossref","first-page":"11473","DOI":"10.1073\/pnas.0604348103","article-title":"Quantitative high-throughput screening: a titration-based approach that efficiently identifies biological activities in large chemical libraries","volume":"103","author":"Inglese","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ab.2012.10.034_b0115","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/108705719900400206","article-title":"A simple statistical parameter for use in evaluation and validation of high throughput screening assays","volume":"4","author":"Zhang","year":"1999","journal-title":"J. Biomol. Screen."},{"key":"10.1016\/j.ab.2012.10.034_b0120","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0009-8981(82)90028-6","article-title":"The use of galactosylceramides with uniform fatty acids as substrates in the diagnosis and carrier detection of Krabbe disease","volume":"126","author":"Mansson","year":"1982","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ab.2012.10.034_b0125","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1073\/pnas.66.2.302","article-title":"Globoid cell leucodystrophy (Krabbe\u2019s disease): deficiency of galactocerebroside-\u03b2-galactosidase","volume":"66","author":"Suzuki","year":"1970","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ab.2012.10.034_b0130","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/ajmg.1320310120","article-title":"Probable metachromatic leukodystrophy\/pseudodeficiency compound heterozygote at the arylsulfatase A locus with neurological and psychiatric symptomatology","volume":"31","author":"Hohenschutz","year":"1988","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.ab.2012.10.034_b0135","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ymgme.2010.09.004","article-title":"An open-label phase I\/II clinical trial of pyrimethamine for the treatment of patients affected with chronic GM2 gangliosidosis (Tay\u2013Sachs or Sandhoff variants)","volume":"102","author":"Clarke","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ab.2012.10.034_b0140","doi-asserted-by":"crossref","first-page":"18","DOI":"10.2183\/pjab.88.18","article-title":"Pharmacological chaperone therapy for Fabry disease","volume":"88","author":"Ishii","year":"2012","journal-title":"Proc. Jpn. Acad. B"},{"key":"10.1016\/j.ab.2012.10.034_b0145","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.cell.2008.06.037","article-title":"Chemical and biological approaches synergize to ameliorate protein-folding diseases","volume":"134","author":"Mu","year":"2008","journal-title":"Cell"}],"container-title":["Analytical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003269712005532?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003269712005532?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T21:07:24Z","timestamp":1757711244000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003269712005532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S0003269712005532"],"URL":"https:\/\/doi.org\/10.1016\/j.ab.2012.10.034","relation":{},"ISSN":["0003-2697"],"issn-type":[{"value":"0003-2697","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A high-throughput screening assay using Krabbe disease patient cells","name":"articletitle","label":"Article Title"},{"value":"Analytical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ab.2012.10.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}